These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33529023)

  • 1. Targeting RECQL5 Functions, by a Small Molecule, Selectively Kills Breast Cancer
    Chakraborty S; Dutta K; Gupta P; Das A; Das A; Ghosh SK; Patro BS
    J Med Chem; 2021 Feb; 64(3):1524-1544. PubMed ID: 33529023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional inhibition of RECQL5 helicase elicits non-homologous end joining response and sensitivity of breast cancers to PARP inhibitor.
    Philip KT; Dutta K; Chakraborty S; Patro BS
    Int J Biochem Cell Biol; 2023 Aug; 161():106443. PubMed ID: 37392863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer.
    Xia HW; Zhang ZQ; Yuan J; Niu QL
    Life Sci; 2021 Jan; 265():118768. PubMed ID: 33217443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells.
    Wang X; Lu X; Zhou G; Lou H; Luo G
    Biosci Rep; 2011 Oct; 31(5):363-9. PubMed ID: 21210765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
    Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
    Patterson K; Arya L; Bottomley S; Morgan S; Cox A; Catto J; Bryant HE
    Oncotarget; 2016 Nov; 7(46):76140-76150. PubMed ID: 27764811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.
    Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G
    Genes Dev; 2007 Dec; 21(23):3073-84. PubMed ID: 18003859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamine-Based Pt(IV) Prodrugs as Substrates for Polyamine Transporters Preferentially Accumulate in Cancer Metastases as DNA and Polyamine Metabolism Dual-Targeted Antimetastatic Agents.
    Liu H; Ma J; Li Y; Yue K; Li L; Xi Z; Zhang X; Liu J; Feng K; Ma Q; Liu S; Guo S; Wang PG; Wang C; Xie S
    J Med Chem; 2019 Dec; 62(24):11324-11334. PubMed ID: 31765154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice.
    Hu Y; Lu X; Luo G
    World J Gastroenterol; 2010 Mar; 16(12):1482-6. PubMed ID: 20333788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability.
    Chen E; Ahn JS; Sykes DB; Breyfogle LJ; Godfrey AL; Nangalia J; Ko A; DeAngelo DJ; Green AR; Mullally A
    Cell Rep; 2015 Dec; 13(11):2345-2352. PubMed ID: 26686625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased RECQL5 correlated with disease progression of osteosarcoma.
    Wu J; Zhi L; Dai X; Cai Q; Ma W
    Biochem Biophys Res Commun; 2015 Nov; 467(4):617-22. PubMed ID: 26499077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRPS1 silencing reverses cisplatin resistance in human breast cancer cells.
    He M; Chao L; You YP
    Biochem Cell Biol; 2017 Jun; 95(3):385-393. PubMed ID: 28177767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells.
    Wang J; Dong Y; Ma H; Wu L; Zhen X; Tang L; Jin J; Han S; Zhang P; Peng J
    J Biol Chem; 2022 Jan; 298(1):101443. PubMed ID: 34822842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECQL5 plays an essential role in maintaining genome stability and viability of triple-negative breast cancer cells.
    Peng J; Tang L; Cai M; Chen H; Wong J; Zhang P
    Cancer Med; 2019 Aug; 8(10):4743-4752. PubMed ID: 31231988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the RecQ helicase mechanism revealed by the structure of the helicase domain of human RECQL5.
    Newman JA; Aitkenhead H; Savitsky P; Gileadi O
    Nucleic Acids Res; 2017 Apr; 45(7):4231-4243. PubMed ID: 28100692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct inhibition of RNA polymerase II transcription by RECQL5.
    Aygün O; Xu X; Liu Y; Takahashi H; Kong SE; Conaway RC; Conaway JW; Svejstrup JQ
    J Biol Chem; 2009 Aug; 284(35):23197-203. PubMed ID: 19570979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis.
    Lin Y; Chen H; Wang X; Xiang J; Wang H; Peng J
    Exp Mol Pathol; 2020 Aug; 115():104477. PubMed ID: 32497619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VR23: A Quinoline-Sulfonyl Hybrid Proteasome Inhibitor That Selectively Kills Cancer via Cyclin E-Mediated Centrosome Amplification.
    Pundir S; Vu HY; Solomon VR; McClure R; Lee H
    Cancer Res; 2015 Oct; 75(19):4164-75. PubMed ID: 26238784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.
    Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S
    Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.